Saberi, M., Ramazani, Z., Rashidi, H., & Saberi, A. (2020). The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy. Vasc Health Risk Manag.
Παραπομπή Chicago StyleSaberi, Meisam, Zahra Ramazani, Homeira Rashidi, και Alihossein Saberi. "The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes On the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy." Vasc Health Risk Manag 2020.
Παραπομπή MLASaberi, Meisam, Zahra Ramazani, Homeira Rashidi, και Alihossein Saberi. "The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes On the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy." Vasc Health Risk Manag 2020.